Back |
home / stock / kod / kod message board
Subject | By | Source | When |
---|---|---|---|
$KOD run started just 3 wks ago @ | TheFinalCD | investorshub | 12/24/2019 7:28:39 PM |
$KOD > powerhouse > new hod 77.15 | crudeoil24 | investorshub | 12/24/2019 6:00:08 PM |
74.79 > new 52 week high! | crudeoil24 | investorshub | 12/24/2019 4:09:54 PM |
PT > $82. > Kodiak Sciences shares are | crudeoil24 | investorshub | 12/24/2019 3:56:20 PM |
$KOD buy 66.60 | stocktrademan | investorshub | 12/19/2019 7:50:21 PM |
Kodiak Sciences Is Maintained at Overweight by Morgan Stanley | crudeoil24 | investorshub | 12/17/2019 5:57:24 PM |
$KOD > powerful upside moves! | crudeoil24 | investorshub | 12/16/2019 6:44:35 PM |
$KOD back on upside track! > 66+ | crudeoil24 | investorshub | 12/09/2019 3:55:37 PM |
$KOD up huge this morning | TheFinalCD | investorshub | 12/05/2019 12:02:47 PM |
* * $KOD Video Chart 12-04-2019 * * | ClayTrader | investorshub | 12/04/2019 11:05:02 PM |
$KOD closes @ 73.40 up 49%. > 4.8M vol. | crudeoil24 | investorshub | 12/04/2019 9:05:31 PM |
Fabulous day > 67.70 new hod! | crudeoil24 | investorshub | 12/04/2019 7:03:05 PM |
Hedge fund Baker Bros. Advisors bullish on $KOD. | crudeoil24 | investorshub | 12/04/2019 4:54:10 PM |
Going to break $60.00 again today. | crudeoil24 | investorshub | 12/04/2019 4:36:30 PM |
Kodiak Sciences agreed to sell future royalties of | crudeoil24 | investorshub | 12/04/2019 1:28:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results PR Newswire PALO ALTO, Calif. , May 15, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the qu...
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy PR Newswire PALO ALTO, Calif. , May 13, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to r...
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform PR Newswire Tarcocimab clinical and non-clinical data high...